ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Amortization of Deferred Charges of $30223.0 for Q1 2026, down 4.95% year-over-year from $31797.0 in Q1 2025, and up 2.75% quarter-over-quarter from $29415.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Amortization of Deferred Charges for 9 consecutive years, with $30223.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 4.95% year-over-year to $30223.0; the TTM figure through Mar 2026 stood at $111675.0 (down 26.09% YoY), while the FY2025 annual figure was $113249.0, down 29.08% from the prior year.
- Amortization of Deferred Charges improved to $30223.0 in Q1 2026 per NDRA's latest filing, from $29415.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $42513.0 in Q3 2024 and bottomed at $23434.0 in Q2 2025.
- Historically, Amortization of Deferred Charges has averaged $34851.6 across 5 years, with a median of $35363.0 in 2024.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 90.15% — and 2025, when it slumped 43.44%.
- ENDRA Life Sciences' Amortization of Deferred Charges stood at $35640.0 in 2022, then gained by 10.44% to $39360.0 in 2023, then slipped by 10.15% to $35363.0 in 2024, then retreated by 16.82% to $29415.0 in 2025, then rose by 2.75% to $30223.0 in 2026.
- Business Quant data shows NDRA's Amortization of Deferred Charges at $30223.0 in Q1 2026, $29415.0 in Q4 2025, and $28603.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,223.00 |
| Mar 31, 2026 | 30,223.00 |
| Dec 31, 2025 | 29,415.00 |
| Dec 31, 2025 | 29,415.00 |
| Sep 30, 2025 | 28,603.00 |
| Sep 30, 2025 | 28,603.00 |
| Jun 30, 2025 | 23,434.00 |
| Jun 30, 2025 | 23,434.00 |
| Mar 31, 2025 | 31,797.00 |
| Mar 31, 2025 | 31,797.00 |
| Dec 31, 2024 | 35,363.00 |
| Dec 31, 2024 | 35,363.00 |
| Sep 30, 2024 | 42,513.00 |
| Sep 30, 2024 | 42,513.00 |
| Jun 30, 2024 | 41,431.00 |
| Jun 30, 2024 | 41,431.00 |
| Mar 31, 2024 | 40,376.00 |
| Mar 31, 2024 | 40,376.00 |
| Dec 31, 2023 | 39,360.00 |
| Dec 31, 2023 | 39,360.00 |